Summary: Featuring articles on screening for retinopathy in type 1 diabetes, variability in lipid reduction with bococizumab, cardiovascular outcomes with bococizumab, eltrombopag and immunosuppression for aplastic anemia, and risankizumab vs. ustekinumab for plaque psoriasis; a review article on sickle cell disease; a case report of a man with nephropathy; and Perspective articles on the Republicans' health care reform muddle, on a citizen's pathway gone astray, on addressing the opioid epidemic, and on reevaluating eligibility criteria.
